Free Trial
OTCMKTS:IOBCF

Ion Beam Applications (IOBCF) Stock Price, News & Analysis

Ion Beam Applications logo
$11.15 0.00 (0.00%)
As of 05/9/2025

About Ion Beam Applications Stock (OTCMKTS:IOBCF)

Key Stats

Today's Range
$11.15
$11.15
50-Day Range
$10.15
$14.05
52-Week Range
$10.15
$15.75
Volume
N/A
Average Volume
792 shs
Market Capitalization
N/A
P/E Ratio
131.54
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

Receive IOBCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ion Beam Applications and its competitors with MarketBeat's FREE daily newsletter.

IOBCF Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
IBA Notice of Full Year 2024 Results and Conference Call
See More Headlines

IOBCF Stock Analysis - Frequently Asked Questions

Ion Beam Applications' stock was trading at $13.85 at the beginning of 2025. Since then, IOBCF stock has decreased by 19.5% and is now trading at $11.15.
View the best growth stocks for 2025 here
.

Shares of IOBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/11/2025
Next Earnings (Estimated)
5/22/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
OTCMKTS:IOBCF
CIK
N/A
Fax
N/A
Employees
2,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
131.54
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:IOBCF) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners